Publications

• Inhibiting FAT1 Blocks Metabolic Bypass to Enhance Antitumor Efficacy of TCA Cycle Inhibition through Suppressing CPT1A-Dependent Fatty Acid Oxidation.
  Adv Sci (Weinh) Page(s): e02146
  05/23/2025 Authors: Chen F; Yang J; Popoola DO; Yang F; Liu Y; Wang D; Qin ZS; Chen Z; Saba NF; Chen ZG
• Blocking the TCA Cycle in Cancer Cells Potentiates CD36+ T-cell-Mediated Antitumor Immunity by Suppressing ER Stress-Associated THBS2 Signaling.
  Cancer Res Page(s): OF1 - OF13
  04/28/2025 Authors: Yang J; Chen F; Fu Z; Yang F; Saba NF; Teng Y
• Neuronal CDK5RAP3 deficiency leads to encephalo-dysplasia via upregulation of N-glycosylases and glycogen deposition.
  Cell Death Discov Volume: 11 Page(s): 146
  04/06/2025 Authors: Chen F; Xiang M; Wang Z; Yang F; Zhou J; Deng Z; Wang S; Li P; Tew J; Zhang W
• Tumor secretome shapes the immune landscape during cancer progression.
  J Exp Clin Cancer Res Volume: 44 Page(s): 47
  02/10/2025 Authors: Yang J; Tang S; Saba NF; Shay C; Teng Y
• SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis.
  Biomark Res Volume: 13 Page(s): 8
  01/09/2025 Authors: Chen F; Lang L; Yang J; Yang F; Tang S; Fu Z; Saba NF; Luo M; Teng Y
• Leveraging Saliva for Insights into Head and Neck Cancer.
  Int J Mol Sci Volume: 25
  12/17/2024 Authors: Rashid S; Puttagunta P; Pamulapati S; Yang J; Pocha S; Saba NF; Teng Y
• Calcium nanoparticles target and activate T cells to enhance anti-tumor function.
  Nat Commun Volume: 15 Page(s): 10095
  11/21/2024 Authors: Yang W; Feng Z; Lai X; Li J; Cao Z; Jiang F; Chen F; Zhan S; Kong F; Yang L
• Tryptophan 2,3-dioxygenase-positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine-mediated ferroptosis resistance of metastatic cells and T cell dysfunction.
  Cancer Commun (Lond) Volume: 44 Page(s): 1261 - 1286
  11/01/2024 Authors: Liu Y; Chen S; Wan X; Wang R; Luo H; Chang C; Dai P; Gan Y; Guo Y; Hou Y
• Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.
  Clin Cancer Res Volume: 30 Page(s): 4601 - 4608
  10/15/2024 Authors: Saba NF; Chaudhary R; Kirtane K; Marra A; Ekpenyong A; McCook-Veal A; Schmitt NC; Gross JH; Patel MR; Remick J
• Therapeutic Targeting of the GLS1-c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer.
  Cancer Res Volume: 84 Page(s): 3223 - 3234
  10/01/2024 Authors: Yang J; Chen F; Lang L; Yang F; Fu Z; Martinez J; Cho A; Saba NF; Teng Y
• Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage.
  Head Neck Volume: 46 Page(s): 2167 - 2177
  09/01/2024 Authors: Pamulapati S; Abousaud M; Li Y; Ekpenyong A; Rudra S; Remick JS; Bates JE; Stokes WA; McDonald MW; Schmitt NC
• Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
  Nat Med Volume: 30 Page(s): 2373
  08/01/2024 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S
• Exploring the impact of GSTM1 as a novel molecular determinant of survival in head and neck cancer patients of African descent.
  J Exp Clin Cancer Res Volume: 43 Page(s): 203
  07/23/2024 Authors: Yang F; Chen F; Shay C; Chen GZ; Saba NF; Teng Y
• Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles.
  Nano Lett Volume: 24 Page(s): 8080 - 8088
  07/03/2024 Authors: Popoola DO; Cao Z; Men Y; Li X; Viapiano M; Wilkens S; Luo J; Teng Y; Meng Q; Li Y
• Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
  JAMA Oncol Volume: 10 Page(s): 896 - 904
  07/01/2024 Authors: Saba NF; Wong SJ; Nasti T; McCook-Veal AA; McDonald MW; Stokes WA; Anderson AM; Ekpenyong A; Rupji M; Abousaud M
• Cell death shapes cancer immunity: spotlighting PANoptosis.
  J Exp Clin Cancer Res Volume: 43 Page(s): 168
  06/15/2024 Authors: Gao L; Shay C; Teng Y
• Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entities.
  Virchows Arch Volume: 484 Page(s): 885 - 900
  06/01/2024 Authors: Sklov A; Agaimy A; Bradova M; Poorten VV; Hanna E; Guntinas-Lichius O; Franchi A; Hellquist H; Simpson RHW; Lopz F
• Combination of Molecule-Targeted Therapy and Photodynamic Therapy Using Nanoformulated Verteporfin for Effective Uveal Melanoma Treatment.
  Mol Pharm Volume: 21 Page(s): 2340 - 2350
  05/06/2024 Authors: Song M; Zhu L; Zhang L; Ge X; Cao J; Teng Y; Tian R
• Identification and analysis of the molecular targets of statins in colorectal cancer.
  Pathol Res Pract Volume: 256 Page(s): 155258
  04/01/2024 Authors: Firouzjaei AA; Mahmoudi A; Almahmeed W; Teng Y; Kesharwani P; Sahebkar A
• Modulation of Dendritic Cell Function via Nanoparticle-Induced Cytosolic Calcium Changes.
  ACS Nano Volume: 18 Page(s): 7618 - 7632
  03/12/2024 Authors: Cao Z; Yang X; Yang W; Chen F; Jiang W; Zhan S; Jiang F; Li J; Ye C; Lang L
• Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer.
  J Exp Clin Cancer Res Volume: 43 Page(s): 76
  03/12/2024 Authors: Yang F; Yuan C; Chen F; Qin ZS; Schmitt NC; Lesinski GB; Saba NF; Teng Y
• HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer.
  Sci Adv Volume: 10 Page(s): eadk3663
  02/23/2024 Authors: Chen F; Tang C; Yang F; Ekpenyong A; Qin R; Xie J; Momen-Heravi F; Saba NF; Teng Y
• Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.
  Laryngoscope Volume: 134 Page(s): 577 - 581
  02/01/2024 Authors: So RJ; Hidalgo Lopez JC; Ballestas SA; Klein AM; Steuer C; Shin DM; Abousaud M; Teng Y; Saba NF; Tkaczuk AT
• Cancer metabolism and carcinogenesis.
  Exp Hematol Oncol Volume: 13 Page(s): 10
  01/29/2024 Authors: Yang J; Shay C; Saba NF; Teng Y
• Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53.
  Cancer Immunol Immunother Volume: 73 Page(s): 10
  01/17/2024 Authors: Kinney BLC; Gunti S; Kansal V; Parrish CJ; Saba NF; Teng Y; Henry MK; Su F-Y; Kwong GA; Schmitt NC
• Nicotinic acetylcholine receptor CHRNA5 is overexpressed in head and neck squamous cell carcinoma patients with a recent tobacco smoking history.
  MicroPubl Biol Volume: 2024
  01/01/2024 Authors: McGuinness CB; White SR; Gray EV; Leonard MV; Teng Y; Shull AY
• Therapeutically harnessing cancer stem cell-derived exosomes.
  Oncotarget Volume: 14 Page(s): 995 - 996
  12/20/2023 Authors: Teng Y
• The mitochondrial fusion protein OPA1 is dispensable in the liver and its absence induces mitohormesis to protect liver from drug-induced injury.
  Nat Commun Volume: 14 Page(s): 6721
  10/23/2023 Authors: Lee H; Lee TJ; Galloway CA; Zhi W; Xiao W; de Mesy Bentley KL; Sharma A; Teng Y; Sesaki H; Yoon Y
• Iron, Ferroptosis, and Head and Neck Cancer.
  Int J Mol Sci Volume: 24
  10/12/2023 Authors: Teng Y; Gao L; Mkitie AA; Florek E; Czarnywojtek A; Saba NF; Ferlito A
• Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis.
  Laryngoscope Volume: 133 Page(s): 2725 - 2733
  10/01/2023 Authors: Ballestas SA; Hidalgo Lopez J; Klein AM; Steuer C; Shin DM; Abousaud M; Schmitt NC; Teng Y; Saba NF; Tkaczuk AT
• Transcriptomic comparison of two selective retinal cell ablation paradigms in zebrafish reveals shared and cell-specific regenerative responses.
  PLoS Genet Volume: 19 Page(s): e1010905
  10/01/2023 Authors: Emmerich K; Walker SL; Wang G; White DT; Ceisel A; Wang F; Teng Y; Chunawala Z; Graziano G; Nimmagadda S
• Retraction Note: Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis.
  Cell Death Dis Volume: 14 Page(s): 640
  09/28/2023 Authors: Peng M; Yang D; Hou Y; Liu S; Zhao M; Qin Y; Chen R; Teng Y; Liu M
• Harnessing cancer stem cell-derived exosomes to improve cancer therapy.
  J Exp Clin Cancer Res Volume: 42 Page(s): 131
  05/23/2023 Authors: Yang J; Teng Y
• Loss of Ufl1/Ufbp1 in hepatocytes promotes liver pathological damage and carcinogenesis through activating mTOR signaling.
  J Exp Clin Cancer Res Volume: 42 Page(s): 110
  05/03/2023 Authors: Chen F; Sheng L; Zhou T; Yan L; Loveless R; Li H; Teng Y; Cai Y
• Remodeling of Mitochondria in Cancer and Other Diseases.
  Int J Mol Sci Volume: 24
  04/22/2023 Authors: Teng Y
• CDK5RAP3, a key defender of udder, modulates NLRP3 inflammasome activation by regulating autophagolysosome degradation in S. agalactiae-infected mastitis.
  Int J Biol Macromol Volume: 234 Page(s): 123714
  04/15/2023 Authors: Yan H; Zhou T; Wang Y; Liu Z; Ali I; Sheng L; Jiang Q; Li T; Xiang M; Li P
• Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
  Nat Med Volume: 29 Page(s): 880 - 887
  04/01/2023 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S
• Adaptive c-Met-PLXDC2 Signaling Axis Mediates Cancer Stem Cell Plasticity to Confer Radioresistance-associated Aggressiveness in Head and Neck Cancer.
  Cancer Res Commun Volume: 3 Page(s): 659 - 671
  04/01/2023 Authors: Lang L; Chen F; Li Y; Shay C; Yang F; Dan H; Chen ZG; Saba NF; Teng Y
• Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer.
  Cancers (Basel) Volume: 15
  03/24/2023 Authors: Saba NF; Pamulapati S; Patel B; Mody M; Strojan P; Takes R; Mkitie AA; Cohen O; Pace-Asciak P; Vermorken JB
• Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States.
  J Exp Clin Cancer Res Volume: 42 Page(s): 4
  01/05/2023 Authors: Yang F; Shay C; Abousaud M; Tang C; Li Y; Qin Z; Saba NF; Teng Y
• Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development.
  J Exp Clin Cancer Res Volume: 42 Page(s): 1
  01/02/2023 Authors: Gao L; Yang F; Tang D; Xu Z; Tang Y; Yang D; Sun D; Chen Z; Teng Y
• The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme.
  Curr Med Chem Volume: 30 Page(s): 857 - 877
  01/01/2023 Authors: Sanati M; Aminyavari S; Mollazadeh H; Motamed-Sanaye A; Bibak B; Mohtashami E; Teng Y; Afshari AR; Sahebkar A
• Mitochondrial regulator ATAD3A: a molecular determinant favoring head and neck cancer development.
  Oncoscience Volume: 10 Page(s): 6 - 8
  01/01/2023 Authors: Teng Y
• Editorial: Metabolome in gastrointestinal cancer.
  Front Oncol Volume: 13 Page(s): 1234242
  01/01/2023 Authors: Isidoro C; Teng Y
• Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck.
  Front Oncol Volume: 13 Page(s): 1310106
  01/01/2023 Authors: Puttagunta P; Pamulapati SV; Bates JE; Gross JH; Stokes WA; Schmitt NC; Steuer C; Teng Y; Saba NF
• GTPase Pathways in Health and Diseases.
  Cells Volume: 11
  12/15/2022 Authors: Teng Y
• In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications.
  Biomaterials Volume: 291 Page(s): 121876
  12/01/2022 Authors: Huang K; Zapata D; Tang Y; Teng Y; Li Y
• The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss.
  J Natl Cancer Inst Volume: 114 Page(s): 1333 - 1337
  10/06/2022 Authors: Lalonde CS; Teng Y; Burtness BA; Ferris RL; Ahmed R; Saba NF
• The regenerative potential of glial progenitor cells and reactive astrocytes in CNS injuries.
  Neurosci Biobehav Rev Volume: 140 Page(s): 104794
  09/01/2022 Authors: Kiaie N; Gorabi AM; Loveless R; Teng Y; Jamialahmadi T; Sahebkar A
• The diverse functions of FAT1 in cancer progression: good, bad, or ugly?
  J Exp Clin Cancer Res Volume: 41 Page(s): 248
  08/15/2022 Authors: Chen ZG; Saba NF; Teng Y
• The cross-talk between soluble "Find me" and "Keep out" signals as an initial step in regulating efferocytosis.
  J Cell Physiol Volume: 237 Page(s): 3113 - 3126
  08/01/2022 Authors: Tajbakhsh A; Yousefi F; Abedi SM; Rezaee M; Savardashtaki A; Teng Y; Sahebkar A
• Radiodynamic therapy with CsI(na)@MgO nanoparticles and 5-aminolevulinic acid.
  J Nanobiotechnology Volume: 20 Page(s): 330
  07/16/2022 Authors: Jiang F; Lee C; Zhang W; Jiang W; Cao Z; Chong HB; Yang W; Zhan S; Li J; Teng Y
• Recent advances in nanogold as a promising nanocarrier for curcumin delivery.
  Colloids Surf B Biointerfaces Volume: 215 Page(s): 112481
  07/01/2022 Authors: Mahmoudi A; Kesharwani P; Majeed M; Teng Y; Sahebkar A
• CDK5RAP3, an essential regulator of checkpoint, interacts with RPL26 and maintains the stability of cell growth.
  Cell Prolif Volume: 55 Page(s): e13240
  05/01/2022 Authors: Yan H; Xu J-J; Ali I; Zhang W; Jiang M; Li G; Teng Y; Zhu G; Cai Y
• Integrative analysis of TCGA data identifies miRNAs as drug-specific survival biomarkers.
  Sci Rep Volume: 12 Page(s): 6785
  04/26/2022 Authors: Lin S; Zhou J; Xiao Y; Neary B; Teng Y; Qiu P
• Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era.
  Cancers (Basel) Volume: 14
  02/25/2022 Authors: Saba NF; Vijayvargiya P; Vermorken JB; Rodrigo JP; Willems SM; Zidar N; de Bree R; Mkitie A; Wolf GT; Argiris A
• ATAD3A mediates activation of RAS-independent mitochondrial ERK1/2 signaling, favoring head and neck cancer development.
  J Exp Clin Cancer Res Volume: 41 Page(s): 43
  01/29/2022 Authors: Lang L; Loveless R; Dou J; Lam T; Chen A; Wang F; Sun L; Juarez J; Qin ZS; Saba NF
• Label-Free Electrochemical Biosensors to Evaluate the Antioxidant Effect of Tocopherol in Ultraviolet Radiation.
  Methods Mol Biol Volume: 2343 Page(s): 241 - 246
  01/01/2022 Authors: Gao L; Teng Y
• The New Frontier of Three-Dimensional Culture Models to Scale-Up Cancer Research.
  Methods Mol Biol Volume: 2343 Page(s): 3 - 18
  01/01/2022 Authors: Jensen C; Shay C; Teng Y
• PGK1 : An Essential Player in Modulating Tumor Metabolism.
  Methods Mol Biol Volume: 2343 Page(s): 57 - 70
  01/01/2022 Authors: Duncan L; Shay C; Teng Y
• Evaluating the Anticancer Activity of Natural Products Using a Novel 3D Culture Model.
  Methods Mol Biol Volume: 2343 Page(s): 159 - 164
  01/01/2022 Authors: Shay C; Teng Y
• Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.
  J Oncol Volume: 2022 Page(s): 4889807
  01/01/2022 Authors: Mortazavi D; Sohrabi B; Mosallaei M; Nariman-Saleh-Fam Z; Bastami M; Mansoori Y; Daraei A; Zununi Vahed S; Navid S; Saadatian Z
• Potential roles of FAT1 somatic mutation in progression of head and neck cancer.
  Oncoscience Volume: 9 Page(s): 30 - 32
  01/01/2022 Authors: Chen ZG; Teng Y
• Evaluation of the Efficacy of Saracatinib-Loaded Nanoparticles in Lymphatic Metastases of HNSCC with the Aid of Bioluminescence Imaging.
  Methods Mol Biol Volume: 2525 Page(s): 15 - 19
  01/01/2022 Authors: Lang L; Teng Y
• Effectiveness of core needle biopsy in the diagnosis of thyroid lymphoma and anaplastic thyroid carcinoma: A systematic review and meta-analysis.
  Front Endocrinol (Lausanne) Volume: 13 Page(s): 971249
  01/01/2022 Authors: Vander Poorten V; Goedseels N; Triantafyllou A; Sanabria A; Clement PM; Cohen O; Golusinski P; Guntinas-Lichius O; Piazza C; Randolph GW
• Editorial: Developing combined modality therapy with mitochondria-targeting strategy.
  Front Oncol Volume: 12 Page(s): 1111724
  01/01/2022 Authors: Teng Y
• Blockade of glutamine-dependent cell survival augments antitumor efficacy of CPI-613 in head and neck cancer.
  J Exp Clin Cancer Res Volume: 40 Page(s): 393
  12/14/2021 Authors: Lang L; Wang F; Ding Z; Zhao X; Loveless R; Xie J; Shay C; Qiu P; Ke Y; Saba NF
• De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?
  Oral Oncol Volume: 123 Page(s): 105620
  12/01/2021 Authors: Golusinski P; Corry J; Poorten VV; Simo R; Sjgren E; Mkitie A; Kowalski LP; Langendijk J; Braakhuis BJM; Takes RP
• The Hidden Link of Exosomes to Head and Neck Cancer.
  Cancers (Basel) Volume: 13
  11/19/2021 Authors: Teng Y; Gao L; Loveless R; Rodrigo JP; Strojan P; Willems SM; Nathan C-A; Mkitie AA; Saba NF; Ferlito A
• A novel lncRNA ROPM-mediated lipid metabolism governs breast cancer stem cell properties.
  J Hematol Oncol Volume: 14 Page(s): 178
  10/29/2021 Authors: Liu S; Sun Y; Hou Y; Yang L; Wan X; Qin Y; Liu Y; Wang R; Zhu P; Teng Y
• PD-L1 expression patterns in oral cancer as an integrated approach for further prognostic classification.
  Oral Dis Volume: 27 Page(s): 1699 - 1710
  10/01/2021 Authors: Miranda-Galvis M; Rumayor Pia A; Sales de S R; Almeida Leite A; Agustin Vargas P; Calsavara VF; Lpes Pinto CA; Teng Y; Kowalski LP
• Hypoxia-stimulated ATM activation regulates autophagy-associated exosome release from cancer-associated fibroblasts to promote cancer cell invasion.
  J Extracell Vesicles Volume: 10 Page(s): e12146
  09/01/2021 Authors: Xi L; Peng M; Liu S; Liu Y; Wan X; Hou Y; Qin Y; Yang L; Chen S; Zeng H
• SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3.
  J Exp Clin Cancer Res Volume: 40 Page(s): 274
  08/31/2021 Authors: Teng Y; Loveless R; Benson EM; Sun L; Shull AY; Shay C
• Pyroptosis at the forefront of anticancer immunity.
  J Exp Clin Cancer Res Volume: 40 Page(s): 264
  08/24/2021 Authors: Loveless R; Bloomquist R; Teng Y
• The complex roles of efferocytosis in cancer development, metastasis, and treatment.
  Biomed Pharmacother Volume: 140 Page(s): 111776
  08/01/2021 Authors: Tajbakhsh A; Gheibi Hayat SM; Movahedpour A; Savardashtaki A; Loveless R; Barreto GE; Teng Y; Sahebkar A
• Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway.
  J Nanobiotechnology Volume: 19 Page(s): 182
  06/14/2021 Authors: Yang X; Zhang W; Jiang W; Kumar A; Zhou S; Cao Z; Zhan S; Yang W; Liu R; Teng Y
• Ultrasmall Gd@Cdots as a radiosensitizing agent for non-small cell lung cancer.
  Nanoscale Volume: 13 Page(s): 9252 - 9263
  05/28/2021 Authors: Lee C; Liu X; Zhang W; Duncan MA; Jiang F; Kim C; Yan X; Teng Y; Wang H; Jiang W
• Decoy Technology as a Promising Therapeutic Tool for Atherosclerosis.
  Int J Mol Sci Volume: 22
  04/23/2021 Authors: Mahjoubin-Tehran M; Teng Y; Jalili A; Aghaee-Bakhtiari SH; Markin AM; Sahebkar A
• FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis.
  J Exp Clin Cancer Res Volume: 40 Page(s): 93
  03/10/2021 Authors: Lang L; Xiong Y; Prieto-Dominguez N; Loveless R; Jensen C; Shay C; Teng Y
• A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.
  Oncogene Volume: 40 Page(s): 1609 - 1627
  03/01/2021 Authors: Zhu P; He F; Hou Y; Tu G; Li Q; Jin T; Zeng H; Qin Y; Wan X; Qiao Y
• Impacts of Environmental Factors on Head and Neck Cancer Pathogenesis and Progression.
  Cells Volume: 10
  02/13/2021 Authors: Miranda-Galvis M; Loveless R; Kowalski LP; Teng Y
• FAP-Targeted Photodynamic Therapy Mediated by Ferritin Nanoparticles Elicits an Immune Response against Cancer Cells and Cancer Associated Fibroblasts.
  Adv Funct Mater Volume: 31
  02/10/2021 Authors: Zhou S; Zhen Z; Paschall AV; Xue L; Yang X; Bebin-Blackwell A-G; Cao Z; Zhang W; Wang M; Teng Y
• The role of tumor suppressor short non-coding RNAs on breast cancer.
  Crit Rev Oncol Hematol Volume: 158 Page(s): 103210
  02/01/2021 Authors: Salimimoghadam S; Taefehshokr S; Loveless R; Teng Y; Bertoli G; Taefehshokr N; Musaviaroo F; Hajiasgharzadeh K; Baradaran B
• Targeting WASF3 Signaling in Metastatic Cancer.
  Int J Mol Sci Volume: 22
  01/15/2021 Authors: Loveless R; Teng Y
• Multifaceted Roles of Long Non-coding RNAs in Head and Neck Cancer.
  Volume: 1286 Page(s): 107 - 114
  01/01/2021 Authors: Duncan L; Shay C; Teng Y
• Toward a New Era for the Management of Circulating Tumor Cells.
  Volume: 1286 Page(s): 125 - 134
  01/01/2021 Authors: Galvis MM; Romero CS; Bueno TO; Teng Y
• Editorial: Going the Distance: Enabling 3D Cell Culture Systems for Biomedical Research and Drug Treatment.
  Front Mol Biosci Volume: 8 Page(s): 685095
  01/01/2021 Authors: Teng Y; Cho WC
• The Multifaceted Therapeutic Mechanisms of Curcumin in Osteosarcoma: State-of-the-Art.
  J Oncol Volume: 2021 Page(s): 3006853
  01/01/2021 Authors: Zahedipour F; Bolourinezhad M; Teng Y; Sahebkar A
• Editorial: Emerging 3D and Animal Models in Diseases and Therapeutics.
  Front Mol Biosci Volume: 8 Page(s): 831833
  01/01/2021 Authors: Teng Y; Yu X; Cho WC
• The mitochondrial protein ATAD3A promotes cisplatin resistance in oral squamous cell carcinoma.
  Volume: 80
  11/01/2020 Authors: Lang L; Duncan L; Jensen C; Shay C; Teng Y
• Emerging Links between Control of Mitochondrial Protein ATAD3A and Cancer.
  Int J Mol Sci Volume: 21
  10/25/2020 Authors: Lang L; Loveless R; Teng Y
• Targeting Hypoxia-Driven Metabolic Reprogramming to Constrain Tumor Progression and Metastasis.
  Int J Mol Sci Volume: 21
  07/31/2020 Authors: Miranda-Galvis M; Teng Y
• Inactivating the EGFR-Arf1 axis by HDAC-targeted therapy to suppress invasiveness of head and neck squamous cell carcinoma
  Volume: 26 Page(s): 55 - 56
  06/01/2020 Authors: He L; Gao L; Lang L; Shay C; Teng Y
• Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism.
  Cancer Lett Volume: 478 Page(s): 8 - 21
  05/28/2020 Authors: Zhao M; Hou Y; Du Y-E; Yang L; Qin Y; Peng M; Liu S; Wan X; Qiao Y; Zeng H
• CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling.
  J Exp Clin Cancer Res Volume: 39 Page(s): 73
  04/28/2020 Authors: Gao L; Xu Z; Huang Z; Tang Y; Yang D; Huang J; He L; Liu M; Chen Z; Teng Y
• Circumventing AKT-Associated Radioresistance in Oral Cancer by Novel Nanoparticle-Encapsulated Capivasertib.
  Cells Volume: 9
  02/25/2020 Authors: Lang L; Lam T; Chen A; Jensen C; Duncan L; Kong F-C; Kurago ZB; Shay C; Teng Y
• Design and Synthesis of Arf1-Targeting -Dipeptides as Potential Agents against Head and Neck Squamous Cell Carcinoma.
  Cells Volume: 9
  01/24/2020 Authors: Vo-Hoang Y; Paiva S; He L; Estaran S; Teng Y
• Unveiling Tumor Microenvironment Interactions Using Zebrafish Models.
  Front Mol Biosci Volume: 7 Page(s): 611847
  01/01/2020 Authors: Loveless R; Shay C; Teng Y
• Targeting ROS-Mediated Crosstalk Between Autophagy and Apoptosis in Cancer.
  Volume: 1260 Page(s): 1 - 12
  01/01/2020 Authors: Gao L; Loveless J; Shay C; Teng Y
• Visualizing and Evaluating Cancer Cell Growth and Invasion by a Novel 3D Culture System.
  Methods Mol Biol Volume: 2138 Page(s): 167 - 173
  01/01/2020 Authors: Shay C; Lang L; Teng Y
• PI3K Isoform-Selective Inhibitors in Cancer.
  Adv Exp Med Biol Volume: 1255 Page(s): 165 - 173
  01/01/2020 Authors: Duncan L; Shay C; Teng Y
• Is It Time to Start Transitioning From 2D to 3D Cell Culture?
  Front Mol Biosci Volume: 7 Page(s): 33
  01/01/2020 Authors: Jensen C; Teng Y
• Using Genome-Editing Tools to Develop a Novel In Situ Coincidence Reporter Assay for Screening ATAD3A Transcriptional Inhibitors.
  Methods Mol Biol Volume: 2138 Page(s): 159 - 166
  01/01/2020 Authors: Lang L; Teng Y
• Exploiting Plug-and-Play Electrochemical Biosensors to Determine the Role of FGF19 in Sorafenib-Mediated Superoxide and Nitric Oxide Production in Hepatocellular Carcinoma Cells.
  Methods Mol Biol Volume: 2138 Page(s): 175 - 183
  01/01/2020 Authors: Gao L; Teng Y
• Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.
  J Hematol Oncol Volume: 12 Page(s): 132
  12/05/2019 Authors: Lang L; Shay C; Zhao X; Xiong Y; Wang X; Teng Y
• Co-delivery nanoparticle to overcome therapeutic resistance in human head and neck cancer promoted by insufficient Src-targeted treatment
  Volume: 79
  07/01/2019 Authors: Lang L; Shay C; Wang X; Teng Y
• Essential role of autocrine FGF19-FGFR4 signaling in head and neck tumorigenesis
  Volume: 79
  07/01/2019 Authors: Lang L; Gao L; Shay C; Zhao X; Shull A; Teng Y
• Drugging the Small GTPase Pathways in Cancer Treatment: Promises and Challenges.
  Cells Volume: 8
  03/16/2019 Authors: Prieto-Dominguez N; Parnell C; Teng Y
• Nck-associated protein 1 associates with HSP90 to drive metastasis in human non-small-cell lung cancer.
  J Exp Clin Cancer Res Volume: 38 Page(s): 122
  03/11/2019 Authors: Xiong Y; He L; Shay C; Lang L; Loveless J; Yu J; Chemmalakuzhy R; Jiang H; Liu M; Teng Y
• Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis.
  Cell Death Dis Volume: 10 Page(s): 228
  03/08/2019 Authors: Peng M; Yang D; Hou Y; Liu S; Zhao M; Qin Y; Chen R; Teng Y; Liu M
• FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma.
  Oncogene Volume: 38 Page(s): 2394 - 2404
  03/01/2019 Authors: Gao L; Lang L; Zhao X; Shay C; Shull AY; Teng Y
• Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.
  J Exp Clin Cancer Res Volume: 38 Page(s): 84
  02/18/2019 Authors: He L; Gao L; Shay C; Lang L; Lv F; Teng Y
• Intracellular reduction in ATP levels contributes to CYT997-induced suppression of metastasis of head and neck squamous carcinoma.
  J Cell Mol Med Volume: 23 Page(s): 1174 - 1182
  02/01/2019 Authors: Zhao X; Lang L; He L; Gao L; Chyan D; Xiong Y; Li H; Peng H; Teng Y
• Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin 3-p38 MAPK signalling.
  Cancer Lett Volume: 442 Page(s): 320 - 332
  02/01/2019 Authors: Wen S; Hou Y; Fu L; Xi L; Yang D; Zhao M; Qin Y; Sun K; Teng Y; Liu M
• Fibroblast Growth Factor Receptor 4 Targeting in Cancer: New Insights into Mechanisms and Therapeutic Strategies.
  Cells Volume: 8
  01/09/2019 Authors: Lang L; Teng Y
• ATAD3A on the Path to Cancer.
  Volume: 1134 Page(s): 259 - 269
  01/01/2019 Authors: Teng Y; Lang L; Shay C
• PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism.
  Volume: 1134 Page(s): 243 - 258
  01/01/2019 Authors: Lang L; Chemmalakuzhy R; Shay C; Teng Y
• Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression.
  Curr Cancer Drug Targets Volume: 19 Page(s): 17 - 25
  01/01/2019 Authors: Lang L; Shull AY; Teng Y
• Oral Pathobiont Activates Anti-Apoptotic Pathway, Promoting both Immune Suppression and Oncogenic Cell Proliferation.
  Sci Rep Volume: 8 Page(s): 16607
  11/09/2018 Authors: Arjunan P; Meghil MM; Pi W; Xu J; Lang L; El-Awady A; Sullivan W; Rajendran M; Rabelo MS; Wang T
• FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression.
  Mol Carcinog Volume: 57 Page(s): 1616 - 1625
  11/01/2018 Authors: Zhao X; Xu F; Dominguez NP; Xiong Y; Xiong Z; Peng H; Shay C; Teng Y
• Making way for suppressing the FGF19/FGFR4 axis in cancer.
  Future Med Chem Volume: 10 Page(s): 2457 - 2470
  10/01/2018 Authors: Prieto-Dominguez N; Shull AY; Teng Y
• Autophagy blockade sensitizes human head and neck squamous cell carcinoma towards CYT997 through enhancing excessively high reactive oxygen species-induced apoptosis.
  J Mol Med (Berl) Volume: 96 Page(s): 929 - 938
  09/01/2018 Authors: Gao L; Zhao X; Lang L; Shay C; Andrew Yeudall W; Teng Y
• Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib.
  J Hematol Oncol Volume: 11 Page(s): 85
  06/20/2018 Authors: Lang L; Shay C; Xiong Y; Thakkar P; Chemmalakuzhy R; Wang X; Teng Y
• Aqueous Suzuki-Miyaura Reaction with 0.6 Equiv. of Base: Green and Efficient Access to Biaryls and Unsymmetrical Terphenyls
  CHEMISTRYSELECT Volume: 3 Page(s): 6022 - 6027
  06/07/2018 Authors: Li X; Teng Y; Feng F; Hu Q; Yuan Z
• Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report.
  Cell Oncol (Dordr) Volume: 41 Page(s): 85 - 91
  02/01/2018 Authors: Gao L; Shay C; Lv F; Wang X; Teng Y
• The Complexity of DEK Signaling in Cancer Progression.
  Curr Cancer Drug Targets Volume: 18 Page(s): 256 - 265
  01/01/2018 Authors: Teng Y; Lang L; Jauregui CE
• Friend or foe? Mitochondria as a pharmacological target in cancer treatment.
  Future Med Chem Volume: 9 Page(s): 2197 - 2210
  12/01/2017 Authors: Dickerson T; Jauregui CE; Teng Y
• Zebrafish as a model to evaluate peptide-related cancer therapies.
  Amino Acids Volume: 49 Page(s): 1907 - 1913
  12/01/2017 Authors: Shull AY; Hu C-AA; Teng Y
• FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4-GSK3-Nrf2 Signaling.
  Cancer Res Volume: 77 Page(s): 6215 - 6225
  11/15/2017 Authors: Teng Y; Zhao H; Gao L; Zhang W; Shull AY; Shay C
• Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics.
  J Exp Clin Cancer Res Volume: 36 Page(s): 112
  08/23/2017 Authors: Lang L; Shay C; Zhao X; Teng Y
• Zbtb38 is a novel target for spinal cord injury.
  Oncotarget Volume: 8 Page(s): 45356 - 45366
  07/11/2017 Authors: Cai Y; Li J; Zhang Z; Chen J; Zhu Y; Li R; Chen J; Gao L; Liu R; Teng Y
• Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity.
  J Hematol Oncol Volume: 10 Page(s): 118
  06/12/2017 Authors: Teng Y; Cai Y; Pi W; Gao L; Shay C
• Promotion of invasion by mutant RAS is dependent on activation of the WASF3 metastasis promoter gene.
  Genes Chromosomes Cancer Volume: 56 Page(s): 493 - 500
  06/01/2017 Authors: Teng Y; Ngoka L; Cowell JK
• Targeting autophagy as a strategy for drug discovery and therapeutic modulation.
  Future Med Chem Volume: 9 Page(s): 335 - 345
  03/01/2017 Authors: Gao L; Jauregui CE; Teng Y
• Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.
  Oncogene Volume: 36 Page(s): 1546 - 1558
  03/01/2017 Authors: Fang D; Chen H; Zhu JY; Wang W; Teng Y; Ding H-F; Jing Q; Su S-B; Huang S
• Inhibiting ADP-ribosylation factor 1 activation to suppress breast cancer metastasis
  Volume: 77
  02/01/2017 Authors: Teng Y; Chavanieu A; Xie X
• FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib.
  J Exp Clin Cancer Res Volume: 36 Page(s): 8
  01/09/2017 Authors: Gao L; Wang X; Tang Y; Huang S; Hu C-AA; Teng Y
• Targeting the WASF3 regulatory complex to suppress metastasis
  Volume: 40 Page(s): S53 - S53
  01/01/2017 Authors: Cowell JK; Teng Y; Arbab AS; Kennedy EJ
• Suppression of Breast Cancer Metastasis Using Stapled Peptides Targeting the WASF Regulatory Complex.
  Cancer Growth Metastasis Volume: 10 Page(s): 1179064417713197
  01/01/2017 Authors: Cowell JK; Teng Y; Bendzunas NG; Ara R; Arbab AS; Kennedy EJ
• KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma.
  BMC Cancer Volume: 16 Page(s): 815
  10/21/2016 Authors: Shi L; Zhang W; Zou F; Mei L; Wu G; Teng Y
• Stapled peptides: providing the best of both worlds in drug development.
  Future Med Chem Volume: 8 Page(s): 1969 - 1980
  10/01/2016 Authors: Xie X; Gao L; Shull AY; Teng Y
• Suppression of breast cancer metastasis through the inactivation of ADP-ribosylation factor 1.
  Oncotarget Volume: 7 Page(s): 58111 - 58120
  09/06/2016 Authors: Xie X; Tang S-C; Cai Y; Pi W; Deng L; Wu G; Chavanieu A; Teng Y
• WASF3 provides the conduit to facilitate invasion and metastasis in breast cancer cells through HER2/HER3 signaling.
  Oncogene Volume: 35 Page(s): 4633 - 4640
  09/01/2016 Authors: Teng Y; Pi W; Wang Y; Cowell JK
• The WASF3-NCKAP1-CYFIP1 Complex Is Essential for Breast Cancer Metastasis.
  Cancer Res Volume: 76 Page(s): 5133 - 5142
  09/01/2016 Authors: Teng Y; Qin H; Bahassan A; Bendzunas NG; Kennedy EJ; Cowell JK
• Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5(+)CK8(+) epithelial cells.
  Oncogene Volume: 35 Page(s): 3555 - 3564
  07/07/2016 Authors: Wang Z; Kim J; Teng Y; Ding H-F; Zhang J; Hai T; Cowell JK; Yan C
• Critical role and mechanism of WASF3 in HER2/HER3 regulation of breast cancer metastasis
  Volume: 76
  07/01/2016 Authors: Teng Y; Pi W; Cowell J
• ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.
  Oncotarget Volume: 7 Page(s): 39834 - 39845
  06/28/2016 Authors: Davis JE; Xie X; Guo J; Huang W; Chu W-M; Huang S; Teng Y; Wu G
• Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma.
  Oncotarget Volume: 7 Page(s): 26844 - 26855
  05/03/2016 Authors: Yu L; Huang X; Zhang W; Zhao H; Wu G; Lv F; Shi L; Teng Y
• A novel CXCR4-ARF1-MAPK signaling pathway controls prostate tumorigenesis
  Volume: 30
  04/01/2016 Authors: Davis JE; Wu WH; Surrao K; Teng Y; Wu G
• Exploiting plug-and-play electrochemistry for drug discovery.
  Future Med Chem Volume: 8 Page(s): 567 - 577
  04/01/2016 Authors: Gao L; Teng Y
• FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3/- catenin signaling cascade via FGFR4 activation.
  Oncotarget Volume: 7 Page(s): 13575 - 13586
  03/22/2016 Authors: Zhao H; Lv F; Liang G; Huang X; Wu G; Zhang W; Yu L; Shi L; Teng Y
• Targeting the WASF3-CYFIP1 Complex Using Stapled Peptides Suppresses Cancer Cell Invasion.
  Cancer Res Volume: 76 Page(s): 965 - 973
  02/15/2016 Authors: Teng Y; Bahassan A; Dong D; Hanold LE; Ren X; Kennedy EJ; Cowell JK
• Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein.
  Oncogene Volume: 35 Page(s): 333 - 343
  01/21/2016 Authors: Teng Y; Ren X; Li H; Shull A; Kim J; Cowell JK
• UFBP1, a Key Component of the Ufm1 Conjugation System, Is Essential for Ufmylation-Mediated Regulation of Erythroid Development.
  PLoS Genet Volume: 11 Page(s): e1005643
  11/01/2015 Authors: Cai Y; Pi W; Sivaprakasam S; Zhu X; Zhang M; Chen J; Makala L; Lu C; Wu J; Teng Y
• Mitochondrial ATAD3A combines with GRP78 to regulate the stability of the WASF3 metastasis-promoting gene
  Volume: 75
  08/01/2015 Authors: Teng Y; Ren X; Cowell J
• Mutations in HSP70-2 gene change the susceptibility to clinical mastitis in Chinese Holstein.
  Gene Volume: 559 Page(s): 62 - 72
  03/15/2015 Authors: Huang P; Lu C; Li J; Xu J; Liu Z; Wang Q; Wang Z; Huo J; Li H; Teng Y
• The promise of zebrafish as a chemical screening tool in cancer therapy.
  Future Med Chem Volume: 7 Page(s): 1395 - 1405
  01/01/2015 Authors: Xie X; Ross JL; Cowell JK; Teng Y
• NOV C-ter: A novel preclinical anti-angiogenic agent
  Volume: 74
  10/01/2014 Authors: Luo J; Teng Y; Li M; Johnson TS; Cuttitta F; Chu Z; Qi X; Cowell JK; Rixe O
• Upregulation of ADP-ribosylation factor 1 contributes to the enhanced activation of the MAPK ERK1/2 in prostate cancer cells
  Volume: 28
  04/01/2014 Authors: Davis J; Teng Y; Guo J; Wu G
• SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells.
  Neoplasia Volume: 16 Page(s): 279-90.e1-5
  04/01/2014 Authors: Hong S; Noh H; Teng Y; Shao J; Rehmani H; Ding H-F; Dong Z; Su S-B; Shi H; Kim J
• WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cells.
  Oncogene Volume: 33 Page(s): 203 - 211
  01/09/2014 Authors: Teng Y; Mei Y; Hawthorn L; Cowell JK
• The involvement of JAK-STAT3 in cell motility, invasion, and metastasis.
  JAKSTAT Volume: 3 Page(s): e28086
  01/01/2014 Authors: Teng Y; Ross JL; Cowell JK
• Evaluating human cancer cell metastasis in zebrafish.
  BMC Cancer Volume: 13 Page(s): 453
  10/04/2013 Authors: Teng Y; Xie X; Walker S; White DT; Mumm JS; Cowell JK
• Critical role of the WASF3 gene in JAK2/STAT3 regulation of cancer cell motility.
  Carcinogenesis Volume: 34 Page(s): 1994 - 1999
  09/01/2013 Authors: Teng Y; Ghoshal P; Ngoka L; Mei Y; Cowell JK
• COP1 and GSK3 cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.
  Neoplasia Volume: 15 Page(s): 1075 - 1085
  09/01/2013 Authors: Shao J; Teng Y; Padia R; Hong S; Noh H; Xie X; Mumm JS; Dong Z; Ding H-F; Cowell J
• Mycophenolic acid inhibits migration and invasion of gastric cancer cells via multiple molecular pathways.
  PLoS One Volume: 8 Page(s): e81702
  01/01/2013 Authors: Dun B; Sharma A; Teng Y; Liu H; Purohit S; Xu H; Zeng L; She J-X
• Silencer-delimited transgenesis: NRSE/RE1 sequences promote neural-specific transgene expression in a NRSF/REST-dependent manner.
  BMC Biol Volume: 10 Page(s): 93
  11/30/2012 Authors: Xie X; Mathias JR; Smith M-A; Walker SL; Teng Y; Distel M; Kster RW; Sirotkin HI; Saxena MT; Mumm JS
• HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions.
  Int J Cancer Volume: 131 Page(s): E905 - E915
  09/15/2012 Authors: Ghoshal P; Teng Y; Lesoon LA; Cowell JK
• Complete sequence of a viral nervous necrosis virus (NNV) isolated from red-spotted grouper (Epinephelus akaara) in China.
  Arch Virol Volume: 157 Page(s): 777 - 782
  04/01/2012 Authors: Liu H; Teng Y; Zheng X; Wu Y; Xie X; He J; Ye Y; Wu Z
• HSP90 and HSP70 proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein.
  J Biol Chem Volume: 287 Page(s): 10051 - 10059
  03/23/2012 Authors: Teng Y; Ngoka L; Mei Y; Lesoon L; Cowell JK
• Functional interrelationship between the WASF3 and KISS1 metastasis-associated genes in breast cancer cells.
  Int J Cancer Volume: 129 Page(s): 2825 - 2835
  12/15/2011 Authors: Teng Y; Liu M; Cowell JK
• Evaluation of a loop-mediated isothermal amplification assay for rapid diagnosis of soft-shelled turtle iridovirus.
  J Virol Methods Volume: 173 Page(s): 328 - 333
  05/01/2011 Authors: Liu Z; Liu H; Xie X; He J; Luo T; Teng Y
• Loss of zebrafish lgi1b leads to hydrocephalus and sensitization to pentylenetetrazol induced seizure-like behavior.
  PLoS One Volume: 6 Page(s): e24596
  01/01/2011 Authors: Teng Y; Xie X; Walker S; Saxena M; Kozlowski DJ; Mumm JS; Cowell JK
• Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype.
  Hum Mol Genet Volume: 19 Page(s): 4409 - 4420
  11/15/2010 Authors: Teng Y; Xie X; Walker S; Rempala G; Kozlowski DJ; Mumm JS; Cowell JK
• Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases.
  Br J Cancer Volume: 103 Page(s): 1066 - 1075
  09/28/2010 Authors: Teng Y; Ren MQ; Cheney R; Sharma S; Cowell JK
• Development and evaluation of a one-step loop-mediated isothermal amplification for detection of spring viraemia of carp virus.
  J Appl Microbiol Volume: 105 Page(s): 1220 - 1226
  10/01/2008 Authors: Liu Z; Teng Y; Xie X; Li H; Lv J; Gao L; Tian F; Jiang Y; Chu Z; Xie C
• Development of a sensitive and quantitative assay for spring viremia of carp virus based on real-time RT-PCR.
  J Virol Methods Volume: 152 Page(s): 43 - 48
  09/01/2008 Authors: Yue Z; Teng Y; Liang C; Xie X; Xu B; Zhu L; Lei Z; He J; Liu Z; Jiang Y
• Whole-genome transcriptional profiles of a novel marine fish iridovirus, Singapore grouper iridovirus (SGIV) in virus-infected grouper spleen cell cultures and in orange-spotted grouper, Epinephulus coioides.
  Virology Volume: 377 Page(s): 39 - 48
  07/20/2008 Authors: Teng Y; Hou Z; Gong J; Liu H; Xie X; Zhang L; Chen X; Qin QW
• Simultaneous detection of three fish rhabdoviruses using multiplex real-time quantitative RT-PCR assay.
  J Virol Methods Volume: 149 Page(s): 103 - 109
  04/01/2008 Authors: Liu Z; Teng Y; Liu H; Jiang Y; Xie X; Li H; Lv J; Gao L; He J; Shi X
• Characterization of a late gene encoding for MCP in soft-shelled turtle iridovirus (STIV).
  Virus Res Volume: 129 Page(s): 135 - 144
  11/01/2007 Authors: Zhao Z; Teng Y; Liu H; Lin X; Wang K; Jiang Y; Chen H
• Characterization of complete genome sequence of the spring viremia of carp virus isolated from common carp (Cyprinus carpio) in China.
  Arch Virol Volume: 152 Page(s): 1457 - 1465
  01/01/2007 Authors: Teng Y; Liu H; Lv JQ; Fan WH; Zhang QY; Qin QW
• MspI polymorphisms in the 3rd intron of the swine POU1F1 gene and their associations with growth performance.
  J Appl Genet Volume: 46 Page(s): 285 - 289
  01/01/2005 Authors: Song C; Gao B; Teng Y; Wang X; Wang Z; Li Q; Mi H; Jing R; Mao J